Shopping Cart
- Remove All
Your shopping cart is currently empty
AKR1C3-IN-4, a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3) with an IC50 of 0.56 μM, shows potential for castrate-resistant prostate cancer (CRPC) research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $32 | In Stock | |
| 25 mg | $47 | In Stock | |
| 50 mg | $66 | In Stock | |
| 100 mg | $94 | In Stock | |
| 200 mg | $139 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $44 | In Stock |
| Description | AKR1C3-IN-4, a potent and selective inhibitor of aldo-keto reductase 1C3 (AKR1C3) with an IC50 of 0.56 μM, shows potential for castrate-resistant prostate cancer (CRPC) research. |
| Targets&IC50 | AKR1C3:0.56 μM (IC50), AKR1C2:15.1 μM (IC50) |
| In vitro | The IC50 of AKR1C3-IN-4 for AKR1C2 is 15.1 μM[1]. |
| Synonyms | AKR1C3-IN-4 |
| Molecular Weight | 281.23 |
| Formula | C14H10F3NO2 |
| Cas No. | 1284180-11-5 |
| Smiles | OC(=O)c1cccc(Nc2ccc(cc2)C(F)(F)F)c1 |
| Relative Density. | 1.395 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (355.58 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.